In Brief: Research tax credit
Research tax credit: Research and experimentation tax credit would be extended for one year (at cost of $2.2 bil.) under the Administration's FY 1999 budget proposal. Vice President Gore previewed the budget proposal during a Jan. 29 speech at Genentech's headquarters in South San Francisco. Unextended, the R&E credit will expire on June 30, 1998...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth